, World Health Organization. Global tuberculosis Report, 2018.
, Tuberculosis Coalition for Technical Assistance. International Standards for Tuberculosis Care (ISTC). The Hague: Tuberculosis Coalition for Technical Assistance, 2006.
Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes, Lancet, vol.369, pp.2042-2049, 2007. ,
An algorithm for tuberculosis screening and diagnosis in people with HIV, N Engl J Med, vol.362, pp.707-716, 2010. ,
Sensitivity and specificity of fluorescence microscopy for diagnosing pulmonary tuberculosis in a high HIV prevalence setting, Int J Tuberc Lung Dis, vol.13, pp.1130-1136, 2010. ,
, Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MT, 2013.
, World Health Organization. Global tuberculosis report, 2013.
Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis, Int J Tuberc Lung Dis, vol.12, issue.9, pp.1021-1029, 2008. ,
Diagnosing tuberculosis in hospitalized HIV-infected individuals who cannot produce sputum: is urine lipoarabinomannan testing the answer?, BMC Infect Dis, vol.17, p.29282005, 2017. ,
Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral, Lancet Infect Dis, vol.12, issue.3, pp.70251-70252, 2012. ,
, Tuberculosis Diagnostics. Lateral Flow Urine Lipoarabinomannan Assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV, 2016.
Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults, National AIDS Control Council. Kenya HIV estimates report, vol.14, issue.5, 2016. ,
Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya, PLoS ONE, vol.12, issue.1, p.170976, 2017. ,
Good Reporting Practices Task Force Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force, Value in Health, vol.16, pp.231-250, 2013. ,
Choix méthodologiques pour l'é valuation é conomique à la HAS, HAS, 2011. ,
, Guide mé thodologique pour l'é valuation é conomique des stratégies de santé . Recommandations mé thodologiques, 2003.
Is introducing rapid culture into the diagnostic algorithm of smear-negative tuberculosis cost-effective?, The International Journal of Tuberculosis and Lung Disease, vol.18, issue.5, pp.541-546, 2014.,
URL : https://hal.archives-ouvertes.fr/halshs-00991625
, National Institute for Health and Care Excellence, 2013.
Nomenclature de l'amortissement des immobilisations ,
A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group, Am J Public Health, vol.90, pp.1241-1247, 2000. ,
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study, Lancet, vol.380, issue.12, pp.61680-61688, 2010.,
URL : https://hal.archives-ouvertes.fr/hal-00921564
, World Health Organization
Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report, Value in Health, vol.8, issue.5, p.16176491, 2005. ,
Methods for the economic evaluation of health care programme, 2005. ,
, GNI per capita Kenya, currency USD, 2013.
, World Health Organization. Choosing interventions that are cost-effective
, Geneva: WHO, 2014.
, World Health Organization. WHO Guide to Cost-effectiveness Analysis, 2013.
Cost-effectiveness analysis of community active case finding and household contact investigation for tuberculosis case detection in urban Africa, PLoS One, vol.10, issue.2, 2015. ,
Generalized cost-effectiveness analysis for national-level priority-setting in the health sector, Cost Eff Resour Alloc, vol.1, issue.1, 2003. ,
Probabilistic sensitivity analysis using Monte Carlo simulation: A practical approach, Medical Decision Making, vol.5, pp.157-177, 1985. ,
Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses, Exp Rev Pharmacoecon Outcomes Res, vol.1, pp.25-36, 2001. ,
Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods, Statistical Methods in Medical Research, vol.11, issue.6, pp.455-468, 2002. ,
The CE plane: a graphic representation of cost-effectiveness, Med Decis Making, vol.10, issue.26, pp.212-214, 1990. ,
Representing uncertainty: The role of cost-effectiveness acceptability curves, Health Economics, vol.10, pp.779-787, 2001. ,
Interpreting the Results of Cost-Effectiveness Studies, J Am Coll Cardiol, vol.52, issue.25, pp.2119-2126, 2008. ,
Economic foundations of cost-effectiveness analysis, J Heal Econ, vol.16, issue.1, pp.1-31, 1997. ,
, Chest radiography in tuberculosis detection. Summary of current WHO recommendations and guidance on programmatic approaches, 2016.
Cost-Effectiveness in Low-and Middle-Income Countries. A Review of the Debates Surrounding Decision Rules, Pharmacoeconomics, vol.27, issue.11, pp.903-917, 2009. ,
Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals with suspected tuberculosis in Uganda, AIDS, vol.28, issue.9, pp.1307-1314, 2014. ,
Cost-Utility of Lateral-Flow Urine Lipoarabinomannan for Tuberculosis Diagnosis in HIV-infected African Adults, Int J Tuberc Lung Dis, vol.17, issue.4, pp.552-558, 2013. ,
Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study, Lancet Global Health, 2019. ,